CE4F-Cholesterol Esterase

Added to your cart

CE4F-Cholesterol Esterase

Cart subtotal: £0.00

View cart (0) Checkout

#SKU CE4F

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Our Cholesterol Esterase & Oxidase products can be used in both Biosensor and Clinical Chemistry applications. In conjunction with peroxidase they are used for the determination of serum cholesterol. Our Cholesterol Esterase is available from porcine pancreas (CE2) or Pseudomonas sp. (CE4F) to suit your application. Why BBI? + Security of supply – direct relationships with abattoirs and recombinant technology ensure a reliable supply chain + Proven performance – Our Cholesterol enzymes have been used in multiple biosensor and clinical chemistry applications + Complimentary reagents – peroxidase and a range of other enzymes available
CE4F

More information

Attributes

Description

  • Associated Activity
  • Catalase: ≤ 1.0 x 10-2%
  • Recommended Use
  • Determination of serum cholesterol in conjunction with cholesterol oxidase and peroxidase.
  • Lead Time
  • 4 weeks
  • Storage
  • Store desiccated at -15°C or below. Allow to come
  • Shelf Life
  • Please enquire
  • Source
  • Pseudomonas sp.
  • Activity
  • ≥100 U/mg material
  • EC Number
  • 3.1.1.13
  • EINECS
  • 232-808-6
  • Systematic Name
  • Steryl-ester acylhydrolase
  • Unit Definition
  • That amount of enzyme causing the formation of one micromole of hydrogen peroxide (half a micromole of quinoneimine dye) per minute at pH 7.0 and 37°C.

Technical Documents

Product Specification (107.12KB)

Analytical Procedures (118.42KB)

Product Information (300.28KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox